{"id":6153,"date":"2024-01-16T18:34:07","date_gmt":"2024-01-16T18:34:07","guid":{"rendered":"https:\/\/abpath.org\/?p=6153"},"modified":"2024-01-31T13:35:54","modified_gmt":"2024-01-31T13:35:54","slug":"guidelines-for-hematopoietic-and-lymphoid-classifications-repost","status":"publish","type":"post","link":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/","title":{"rendered":"Guidelines for Hematopoietic and Lymphoid Classifications- repost"},"content":{"rendered":"\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-1024x1024.png\" alt=\"\" class=\"wp-image-19\" style=\"width:125px;height:125px\" srcset=\"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-1024x1024.png 1024w, https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-300x300.png 300w, https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-150x150.png 150w, https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-768x768.png 768w, https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo.png 1199w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Notice to 2024 American Board of Pathology Examination Candidates<\/strong><\/h4>\n\n\n\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Topic: Guidelines for Hematopoietic and Lymphoid Classifications<\/strong><\/h4>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>January 16, 2024- &nbsp;In response to recent inquiries, please note the Revised 4th Edition (2016) WHO classification for hematolymphoid neoplasms will be used for the 2023 Primary and Subspecialty examinations. <mark style=\"background-color:#fafd8f\" class=\"has-inline-color\">Starting in 2024, candidates will need to be familiar with both the 2022 International Consensus Classification system and the 5th Edition of the WHO Classification.<\/mark><\/p>\n\n\n\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>For more information on certification exam content visit the <a href=\"https:\/\/abpath.org\/get-certified\/\">Get Certified<\/a> for information on Primary and Subspecialty exam descriptions.<\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><em>This post was originally published on January 25, 2023 and again in August 2023.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Notice to 2024 American Board of Pathology Examination Candidates Topic: Guidelines for Hematopoietic and Lymphoid Classifications January 16, 2024- &nbsp;In response to recent inquiries, please note the Revised 4th Edition (2016) WHO classification for hematolymphoid neoplasms will be used for the 2023 Primary and Subspecialty&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[9,1],"tags":[],"class_list":["post-6153","post","type-post","status-publish","format-standard","hentry","category-training","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Guidelines for Hematopoietic and Lymphoid Classifications- repost - American Board of Pathology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guidelines for Hematopoietic and Lymphoid Classifications- repost - American Board of Pathology\" \/>\n<meta property=\"og:description\" content=\"Notice to 2024 American Board of Pathology Examination Candidates Topic: Guidelines for Hematopoietic and Lymphoid Classifications January 16, 2024- &nbsp;In response to recent inquiries, please note the Revised 4th Edition (2016) WHO classification for hematolymphoid neoplasms will be used for the 2023 Primary and Subspecialty...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/\" \/>\n<meta property=\"og:site_name\" content=\"American Board of Pathology\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/theABPath\/\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/theABPath\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-16T18:34:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-31T13:35:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-1024x1024.png\" \/>\n<meta name=\"author\" content=\"Bonnie Woodworth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TheABPath\" \/>\n<meta name=\"twitter:site\" content=\"@TheABPath\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bonnie Woodworth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guidelines for Hematopoietic and Lymphoid Classifications- repost - American Board of Pathology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/","og_locale":"en_US","og_type":"article","og_title":"Guidelines for Hematopoietic and Lymphoid Classifications- repost - American Board of Pathology","og_description":"Notice to 2024 American Board of Pathology Examination Candidates Topic: Guidelines for Hematopoietic and Lymphoid Classifications January 16, 2024- &nbsp;In response to recent inquiries, please note the Revised 4th Edition (2016) WHO classification for hematolymphoid neoplasms will be used for the 2023 Primary and Subspecialty...","og_url":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/","og_site_name":"American Board of Pathology","article_publisher":"https:\/\/www.facebook.com\/theABPath\/","article_author":"https:\/\/www.facebook.com\/theABPath","article_published_time":"2024-01-16T18:34:07+00:00","article_modified_time":"2024-01-31T13:35:54+00:00","og_image":[{"url":"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-1024x1024.png","type":"","width":"","height":""}],"author":"Bonnie Woodworth","twitter_card":"summary_large_image","twitter_creator":"@TheABPath","twitter_site":"@TheABPath","twitter_misc":{"Written by":"Bonnie Woodworth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/#article","isPartOf":{"@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/"},"author":{"name":"Bonnie Woodworth","@id":"https:\/\/abpath.org\/#\/schema\/person\/f77b22c2d7a0375d9d621705572bcc39"},"headline":"Guidelines for Hematopoietic and Lymphoid Classifications- repost","datePublished":"2024-01-16T18:34:07+00:00","dateModified":"2024-01-31T13:35:54+00:00","mainEntityOfPage":{"@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/"},"wordCount":103,"publisher":{"@id":"https:\/\/abpath.org\/#organization"},"image":{"@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/#primaryimage"},"thumbnailUrl":"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-1024x1024.png","articleSection":["Training"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/","url":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/","name":"Guidelines for Hematopoietic and Lymphoid Classifications- repost - American Board of Pathology","isPartOf":{"@id":"https:\/\/abpath.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/#primaryimage"},"image":{"@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/#primaryimage"},"thumbnailUrl":"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-1024x1024.png","datePublished":"2024-01-16T18:34:07+00:00","dateModified":"2024-01-31T13:35:54+00:00","breadcrumb":{"@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/#primaryimage","url":"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-1024x1024.png","contentUrl":"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo-1024x1024.png"},{"@type":"BreadcrumbList","@id":"https:\/\/abpath.org\/2024\/01\/guidelines-for-hematopoietic-and-lymphoid-classifications-repost\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/abpath.org\/"},{"@type":"ListItem","position":2,"name":"Guidelines for Hematopoietic and Lymphoid Classifications- repost"}]},{"@type":"WebSite","@id":"https:\/\/abpath.org\/#website","url":"https:\/\/abpath.org\/","name":"American Board of Pathology","description":"American Board of Pathology","publisher":{"@id":"https:\/\/abpath.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/abpath.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/abpath.org\/#organization","name":"American Board of Pathology","url":"https:\/\/abpath.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/abpath.org\/#\/schema\/logo\/image\/","url":"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo.png","contentUrl":"https:\/\/abpath.org\/wp-content\/uploads\/2021\/08\/ABPath-logo.png","width":1199,"height":1199,"caption":"American Board of Pathology"},"image":{"@id":"https:\/\/abpath.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/theABPath\/","https:\/\/x.com\/TheABPath","https:\/\/www.linkedin.com\/company\/abpath","https:\/\/www.instagram.com\/theabpath\/"]},{"@type":"Person","@id":"https:\/\/abpath.org\/#\/schema\/person\/f77b22c2d7a0375d9d621705572bcc39","name":"Bonnie Woodworth","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/abpath.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/89e8c65c011df66febeca77a9bbdb4d1db82ad79910edb485c9477843d33b148?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89e8c65c011df66febeca77a9bbdb4d1db82ad79910edb485c9477843d33b148?s=96&d=mm&r=g","caption":"Bonnie Woodworth"},"sameAs":["https:\/\/abpath.org","https:\/\/www.facebook.com\/theABPath","https:\/\/www.instagram.com\/theabpath\/","https:\/\/www.linkedin.com\/company\/abpath","https:\/\/x.com\/TheABPath"],"url":"https:\/\/abpath.org\/author\/bwoodworth\/"}]}},"_links":{"self":[{"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/posts\/6153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/comments?post=6153"}],"version-history":[{"count":4,"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/posts\/6153\/revisions"}],"predecessor-version":[{"id":6319,"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/posts\/6153\/revisions\/6319"}],"wp:attachment":[{"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/media?parent=6153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/categories?post=6153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/abpath.org\/wp-json\/wp\/v2\/tags?post=6153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}